How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Zinc Bisglycinate Market
- By Product Form: Powder, Capsules, Tablets, Liquid, Softgels
- By Application: Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Animal Nutrition
- By End-User: Adults, Children, Elderly, Athletes
- By Distribution Channel: Online Retail, Pharmacies, Health Food Stores, Direct Sales, Supermarkets/Hypermarkets
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Powder leads By Product Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.166 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.174 →
Full report · locked preview
Everything inside the Zinc Bisglycinate Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Form 5
Application 4
End-User 4
Distribution Channel 5
Companies profiled
Balchem Corporation
Albion Minerals
Glanbia Nutritionals
Prinova Group LLC
Zhejiang Medicine Co. Ltd.
Jiangsu Guotai International Group Guomao Co. Ltd.
Nutrablend Foods Pvt. Ltd.
Sabinsa Corporation
Nutraceutical Corporation
AIDP Inc.
Gnosis by Lesaffre
Nutritional Ingredients International Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Balchem Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Albion Minerals
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Glanbia Nutritionals
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Prinova Group LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Zhejiang Medicine Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Jiangsu Guotai International Group Guomao Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Nutrablend Foods Pvt. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Sabinsa Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Nutraceutical Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →AIDP Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Gnosis by Lesaffre
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Nutritional Ingredients International Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Magnevita Nutraceuticals
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Zhejiang NHU Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Jiangsu Boli Bioproducts Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,031M by 2033 · 6.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Powder51.3
- Capsules12.1
- Tablets14.2
- Liquid7.7
- Softgels14.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,417M → $2,139M · 5.3%
Europe$987.8M → $1,564M · 5.9%
Asia Pacific$901.9M → $1,365M · 5.3%
Latin America$558.3M → $816.9M · 4.9%
Middle East and Africa$429.5M → $728.4M · 6.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.302026
6.332027
6.332028
6.342029
6.352030
6.372031
6.382032
6.392033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Balchem Corporation9.8
- Albion Minerals17.1
- Glanbia Nutritionals12.5
- Prinova Group LLC10.3
- Zhejiang Medicine Co. Ltd.11.0
- Jiangsu Guotai International Group Guomao Co. Ltd.11.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Form22.2%
Application34.5%
End-User23.6%
Distribution Channel19.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.3
- Europe23.7
- Asia Pacific20.6
- Latin America12.4
- Middle East and Africa11.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Balchem Corporation | 97 | 99 | 81 | 99 | 80 | 80 | 89 |
| Albion Minerals | 69 | 73 | 68 | 70 | 90 | 80 | 75 |
| Glanbia Nutritionals | 70 | 88 | 63 | 69 | 85 | 86 | 77 |
| Prinova Group LLC | 74 | 73 | 77 | 82 | 82 | 57 | 74 |
| Zhejiang Medicine Co. Ltd. | 76 | 60 | 62 | 75 | 55 | 77 | 68 |
| Jiangsu Guotai International Group Guomao Co. Ltd. | 64 | 64 | 61 | 51 | 48 | 48 | 56 |
| Nutrablend Foods Pvt. Ltd. | 61 | 62 | 49 | 48 | 59 | 62 | 57 |
| Sabinsa Corporation | 36 | 52 | 52 | 48 | 44 | 60 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Balchem Corporation
- Albion Minerals
- Glanbia Nutritionals
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Balchem Corporation | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Albion Minerals | − | ✓ | ◐ | ◐ | ✓ | ✓ |
| Glanbia Nutritionals | ◐ | ◐ | − | ✓ | ✓ | ✓ |
| Prinova Group LLC | ◐ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Zhejiang Medicine Co. Ltd. | ✓ | − | − | ◐ | ◐ | ◐ |
| Jiangsu Guotai International Group Guomao Co. Ltd. | ✓ | ◐ | ◐ | − | − | − |
| Nutrablend Foods Pvt. Ltd. | ◐ | − | − | − | − | ◐ |
| Sabinsa Corporation | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Balchem Corporation89
2Glanbia Nutritionals77
3Albion Minerals75
4Prinova Group LLC74
5Zhejiang Medicine Co. Ltd.68
6Nutrablend Foods Pvt. Ltd.57
7Jiangsu Guotai International Group Guomao Co. Ltd.56
8Sabinsa Corporation49
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Balchem Corporation
Challenger4
Strong scale, closing on the leaders.
Albion MineralsGlanbia NutritionalsPrinova Group LLCZhejiang Medicine Co. Ltd.
Contender1
Focused players with pockets of strength.
Nutrablend Foods Pvt. Ltd.
Niche2
Specialists in a single segment or region.
Jiangsu Guotai International Group Guomao Co. Ltd.Sabinsa Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Form in North America, then scale across Zinc Bisglycinate Market — a $311M beachhead inside a $6.21B market.
Beachhead (SOM)$311Mobtainable near-term
Serviceable (SAM)$2.20Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Powder
Best fit — highest urgency & budget in Product Form.
Economic buyer78 fit
Capsules
Strong fit — clear ROI and a fast path to value.
End user68 fit
Tablets
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel28%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Zinc Bisglycinate Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified24%
Evaluation13%
Closed-won6%
$15.5KCAC
$69KLTV
4.4:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Zinc Bisglycinate Market is a high-growth opportunity — $10.8B by 2033, compounding at 10.5%.
TAM · 2025$4.89Btoday
TAM · 2033$10.8Bforecast
CAGR10.5%2027–2033
Cumulative$67.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.8BTotal addressable market
SAM$4.17BServiceable available market
SOM$805MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Form moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.8BLarge & growingTAM by 2033 at 10.5% CAGR
$4.17BServiceable nowreachable with today’s model
$805MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.45BBear6.8% CAGR
$10.8BBase10.5% CAGR
$13.9BBull13.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Zinc Bisglycinate Market — a $4.27B market by 2033. Plan: grow share from 6.7% to 13.2%.
Market size · 2033$4.27Btotal addressable
Market CAGR6.7%2027–2033
Target share13.2%from 6.7% today
Revenue ambition$564Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.7% | 13.2% | At risk |
| Revenue | $298M | $564M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 29.4% | 44.7% | Behind |
| Customer retention | 89.0% | 95.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $77M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Zinc Bisglycinate Market conversation — a $1.69B market you can size, segment and defend in minutes.
Market size · 2033$1.69Btotal opportunity
Growth5.6%CAGR to 2033
Addressable buyers1,310+accounts in scope
Typical ROI6.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Form
Goal Grow share in Product Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.2×return on cost, year one
< 4 mopayback period
$64K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Balchem CorporationAlbion MineralsGlanbia NutritionalsPrinova Group LLCZhejiang Medicine Co. Ltd.Jiangsu Guotai International Group Guomao Co. Ltd.Nutrablend Foods Pvt. Ltd.Sabinsa Corporation+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Zinc Bisglycinate Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Zinc Bisglycinate Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Zinc and Selenium Supplement Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportZinc Ammonium Citrate Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportZinc-Air Hearing Aid Batteries Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportZinc-air Battery Hearing Aid Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportZinc Acexamate API Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportZinc Acetate Oral Solution Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportZinc Acetate Dihydrate Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportZileuton Market
Market size, share, segmentation and regional forecast.
$414M market · 2025 base year
View reportZika Virus Therapeutic Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportZika Virus Infection Treatment Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportZika Virus IgM Test kit Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportZidovudine API Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.